Limba
Romanian
Romanian
English|
Baricitinib is a selective JAK1and JAK2inhibitor with IC50of 5.9 nM and 5.7 nM in cell-free assays, ~70 and ~10-fold selective versus JAK3 and Tyk2, no inhibition to c-Met and Chk2. Baricitinib is found to reduce or interrupt the passage of the virus into target cells and is used in the treatment research for COVID-19. Phase 3.
| Price | 10.848,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Baricitinib is a selective JAK1and JAK2inhibitor with IC50of 5.9 nM and 5.7 nM in cell-free assays, ~70 and ~10-fold selective versus JAK3 and Tyk2, no inhibition to c-Met and Chk2. Baricitinib is found to reduce or interrupt the passage of the virus into target cells and is used in the treatment research for COVID-19. Phase 3. |
